$102.96
-2.31-2.19%
Pre-Market: 8:41 AM EDT
Comments
Loading...
Latest news for Novo Nordisk (NYSE:NVO) Stock
Novo Nordisk Stock (NYSE: NVO)
Categories: All
Wednesday, November 20, 2024
Tuesday, November 19, 2024
Monday, November 18, 2024
Friday, November 15, 2024
Wednesday, November 13, 2024
- Amgen Defends Its Investigational Monthly Weight Loss Injection After Analyst Cites MariTide's Impact on Bone Density
- What's Going On With Hims & Hers Health Stock On Wednesday?
- Humanitarian Organization Criticizes Eli Lilly, Novo Nordisk And Sanofi Of Having 'Double Standards' For High Insulin Price
- Jim Cramer Says Eli Lilly's 'Pathetic' Stock Performance Could Get A Breather If Amgen Has Hidden Bone Risk Data After 7% Stock Drop
Tuesday, November 12, 2024
Monday, November 11, 2024
Friday, November 08, 2024
Thursday, November 07, 2024
Wednesday, November 06, 2024
- Forecasting The Future: 7 Analyst Projections For Novo Nordisk
- Generic Drug Maker Teva Clocks 13% Jump In Q3 Revenues, Tightens Annual Forecast
- Cantor Fitzgerald Reiterates Overweight on No...
- Ozempic/Wegovy Maker Maintains Q3 Sales Growth On Booming Demand
- Novo Nordisk CFO Sees 2025 Sales Growth Could...
- Novo Nordisk 2024 Outlook, Updated: Now Expec...
- Novo Nordisk Q3 2024 GAAP EPS DKK6.12 Beats D...
Tuesday, November 05, 2024
Monday, November 04, 2024
Friday, November 01, 2024
Thursday, October 31, 2024
Wednesday, October 30, 2024
- Hims & Hers Health Stock Is Trading Lower Wednesday: Here's Why
- AMD Earnings Show Power Of Nvidia Software, ADP Data Defies Expectations
- Reported Earlier, 'Novo Nordisk's Ozempic and...
- How Is The Market Feeling About Novo Nordisk?
- Tiziana Life Sciences Reports Preclinical Res...
- Novo Nordisk shares are trading lower in poss...